Changes in the Treatment of Brucellosis

Fatma SIRMATEL; İbrahim BAYDAR

doi:10.58600/eurjther.19920301-1289

Authors

Fatma SIRMATEL Gaziantep Üniversitesi Tıp Fakültesi Enf.Hast. ve Kl.Bakt.ABD.Yrd.Doç.Dr.
İbrahim BAYDAR Gaziantep Üniversitesi Tıp Fakültesi Enf.Hast. ve Kl.Bakt.ABD.Prof.Dr.

DOI:

https://doi.org/10.58600/eurjther.19920301-1289

Keywords:

Brusellozis, Tedavi

Abstract

Treatment of brucellosis has been changed because of the ineffectiveness of Streptomycin+ Tetracyclin combination and relapses seen frequently following this therapy. Many kinds of antibiotics and their combinations have been used in the treatment.

Combinations with 2 or 3 antibiotics including quinolon antibiotics and 3 rd generation of cephalosporins have been recommended to use at least 6 weeks

Metrics

Metrics Loading ...

References

Wendell H.: HallModem Chemotherapy for Brucellosis in Humans. Rewiev of lnf.Dis.6:1060- 1095, 1990.

Gargani G., Pacetti AM.: Sensitivity of 115 strains of the Genus Brucella to Some Antibiotics. Chemotherapia 5:7-13, 1986.

Özsüt H.:Brusellozis Tedavisi. Klimik Dergisi.3:26-29, 1990.

Bosh J., Linaeres MJ., Goicoecha L., Cisnal MJ.,: in Vitro Activity of Ciprofloxacin Ceftriaxone and Five Other Antimicrobial Agents Against 95 Strains of Brucella melitensis. Journal of Antimicrobial Chemotherapy 17:459-461, 1986.

Guiterrez A., Enciso M., Garcia P., Bueno A.: in Vitro Activity of N.formimidoyl thienamicin (lmipinem) against Clinical Isolates of Brucella melitensis Compared with Those of Cefoxitin, Rifampin, Tetracycline and Cotrimoxale. Antimitrb. Agents Chemoth. 29:82-183. 1986.

Waksmans S., Schatza A.,: Streptomycin: Origins Nature and Properties. Journal of The American Pharmaceutical Scientific Edition.34:273-291, 1945.

Pulanski EJ., Ampsacher WH.: Streptomycine Therapy in Brucellosis. Bulletin of the U.S.A. Army Medical Department.7:221-225, 1947.

Magill GB., Killough JH.: Oxytetracycline-Streptomycine Therapy in Brucellosis Due to Brucella melitensis. Arch. Intern.Med. 91:204-211, 1953.

Joint Fao/Who Expert Committee on Brucellosis: 4 th Brucellosis Report. Who Tech.Report Series. Geneva No:289, 1964.

Paul M., Smaron M., Ormiste V.: Brucellosis in a Group of Travelers to Pain (Brief Reports). JAMA 4:251, 1984.

Cleveland JC., Jsuchor R., Dage J.: Destructive Aortic Valve Endocarditis from Brucella abortis Survial with Emergency Aortic Valve Replacement Thorax. 33:616-618, 1978.

Acocella G., Bertrand A., Bernard BJ.: Comparison of Three Different Regimen in the Treatment of Acute Brucellosis. A Multicenter Multinational Study. Journal of Antimicrobial Chemotherapy. 23:433-439, 1989.

Kılıç SS., Felek S., Aslan İN., Işık A.: Bruselloz Tedavisinde Karşılaştırmalı Bir Çalışma. Ankem Dergisi 3:521-525, 1989.

Ariga J., Guidol F., Domingiez C.: Tratamiento de la Brucellosis Agodu con TMPSMZ in Baquero F.Ed Proceding of the 1 st Mediterranen Congres of Chemotherapy Madrid 769-775, 1978.

Anza F., Gudiol R., Pallares G., Rufib P., Viladrich F.:Comperative Trial of Co-Trimoxazole Versus Tetracycline+Streptomycine in Treating Human Brucellosis. The Journal of lnf.Dıs. 152:1358-1359, 1985.

Orainey JO., Laajam MA., Al-Aska AK., Rajapakse CN.: Brucella Menengitis. Journal of lnfect.Dis. 14:142-145, 1987.

Lorens JL., Busquets RM.: Brucellosis Treated with Rifampicin. Archives of Disease in Childhood. 55:486-489, 1980.

Godeau P., Fuchs G., Guillevin L., Philipper A., Tucat G., Cabare J., Herson S.: Traitement de la Brucellose Humaine par la Rifampicine. Sem.Hosp.60:5-9, 1984.

Joint Fao/Who Expert Committee on Brucellosis: 6 th Brucellosis Report. WHO Tech. Report Series No: 740, 1986.

Saleh M., Yakup BA., Sharif HS., Phadke JG.: Neurobrucellosis, Clinical Characteristics, Diagnosis and Outcome. Neurology, 39:498-501, 1989.

Drutz JE.: Brucellosis of the Central Nervous System. Clinical Pediatrics. 10:476-478, 1989.

Pascual J., Polo CM., Berciand J.: Localized CNS Brucellosis Report of 7 Cases. Acta Neural Scand. 78:282-289, 1988.

Montanari M., Gandini T., Torre D., Dietz A.: La Terapia Della Brucelosi Esperienza Clinica Con L'associazione Rifampicina Doxicina. Minevra Medica 76:1407-1410, 1985.

Cantillo C., Marquez H., Iglesias R., Franquelo C., Diaz R., Alanso A.: Comparative Treal of Doxycycline plus Streptomycuni versus Doxycycline plus Rifampicina for the Therapy ou Human Human Brucellosis. Chemoth. 35:146-152, 1989.

Cisneros JM., Viciana P., Colmenoro J., Martinez C.: Multicenter Prospective Study of Treatment of Brucella melitensis Brucellosis with Doxycycline for 6 Weeks plus Streptomycine for 2 Weeks. Antimicrobial Agents and Chemotherapy 5:881-883, 1990.

Sharma B .. : Treatment of Brucellosis by Nalidixic Acid. Lancet 1:1172-1173, 1965.

Rodriguez G., Sanchez G., Trujillano J., Munoz JL.: İn Vitro Activity of New Quinolones Against Brucella melitensis. Rewievs of lnf.Dis.11:5992, 1989.

Baykal M., Akalın HE., Fırat M., Serin A.: İn Vitro Activity and Clinical Efficacy of Oflaxacin in lnfections Due to Brucella melitensis. Rewievs of lnf.Dis.11:993, 1989:

Khan Y., Dizon M., Kiel W.: Comparative in Vitro Activities of Oflaxacine, Ciprofloxacine and Other Selected Antimicrobial Agents Against Brucella melitensis. Antimicrobial Agents and Chemotherapy 8:1404-1410, 1989.

Gobernado M., Cauton E., Santos M.: in Vitro Activity of Ciprofloxacine Against Brucella melitensis. Bur.J.Oin.Microbial.3:371, 1984.

Bosh J., Linares J., Lopez MJ., Cisnal A., Martin R.: in Vitro Activity of Ciprofloxacin, Ceftriakson and Five Other Antimicrobial Agents Against 95 Strains of Brucella melitensis. J.Antimicrobial Chemoth. 17:459-461, 1986.

Lang R., Roz R., Sacit T., Michael J., Sapira M.: Failure of Prolengen Treatment of Ciprofloxacin in Acute Brucellosis. 28 th ICAAC Book of Absract Page:177, 1988.

Al Sibai MB., El Shaker MM., Quadri H.: The Efficacy of Ciprofloxacin in the Treatment of Brucella in One Year Follow Up. 3 rd lnternational Symp. On New Quinolones Book of Abstr. Page:116, 1990.

AI-Rawit T., Thewaini AJ., Shawket AR., Ahmet M.: Skeletal Brucellosis in lraq Patients. Ann. of Rheuma Diseas. 48:77-79, 1989.

Mousarm RM., Mathaseb SA., Almudaldal DS.: Osteoarticular Complications of Brucellosis. A.Study of 169 Cases. Rev.lnfect.Dıs.9:531-548, 1987.

Khateeb MJ., Araj GF., Majeed S., Lulu A.: Brucella Arthritis. A Study of 96 Cases in Kuwait. Ann. of the Rheumatic Diseas. 49:994-998, 1990.

Sırmatel F., Sırmatel Ö., Baydar İ., Balo İ.: 5 Nörobrusellozis Olgusu. Gaziantep Üniversitesi Tıp Fakültesi Mecmuası. Baskıda.

Bashir R., Zuheir FM., Edward F., Harden J.: Nervous System Brucellosis Dıagnosis and Treatment. Neurology. 35:1576-1581, 1985.

Güvenç H., Kocabay K., Ökten A., Bektaş S.: Brucellosis in a Child Complicated With Multiple Brain Abscesses. Scand.J.Infect.Dis.21:333-336, 1989.

Micozzi A., Venditti M., Gentile G., Alessandri N., Santero M., Partino P.: Successful Treatment of Brucella melitensis Endocarditis with Pefloxacin. Eur. J.Clin. Microbial. lnf.Dis. 157:918-924, 1988.

Akalın HE., Unal S., Gün D., Baykal M.: Oflaxacin in the Treatment of Brucellosis. 3 rd lnternational Symp. on New Quinolones Book of Abstr. Page:177, 1988.

Platt P., Gray J., Carson P.: Brucella Erdocarditis. A Successfully Treated Case. J.lnfection. 2:275- 278, 1980.

Jeroudi MO., Halim MA., Horder EJ.: Brucella Endocarditis. Br.Heart J. 58:279-283, 1987.

Kasab S., Fagih A., Yousef A.: Brucella lnfective Endocarditis. Successful Combined Medical and Surgical Therapy. Thorac Cardiovasc Surg. 95:862

Pellicer T., Arıza J., Foz A., Pallares R., Guidol F.: Specific Antibodies Detected During Relapse of Human Brucellosis. J.lnfec. Dıs.157:918-924, 1988.

ldrissi HY., Uwaydah A., Danso K., Mousa M.: Ceftriaxone in the Treatment of Acute and Subacute Human Brucellosis. The Journal of lnter. Medical Research. 17:363-368, 1989.

Altes AG., Enciso MD., Gorcia PP.: in Vitro Activity of N-Formimidoyl Thienamycin Against 98 Clinical lsolates of Brucella melitensis Compared with Those of Cefoxitis Rifampin Tetracycline and Co-Trimoxazole. Antimicrob. Agents Chemother. 21:501-503, 1982.

Boura P., Raptopoulou M., Acriviades E., Goulis G.: Revaluation of The Effect of Levamisole in Chronic Brucellosis. in Vitro and in Vivo Effect on Monocyte Phagocytosis. J. Immunopharmacology. 6(3):135-146, 1984.

Soung EJ.: Human Brucellosis. Rev.lnfect.Diseas. 5:821-842, 1983,

Palanque E., Otero FR., Noreeaga AR.: in Vitro Susceptibility· of Brucella melitensis to New Cephalosporins Crossing the Blood-Brain Barrier.Anti microb.Agent Chemoth. 29:182-183, 1986.